Report Detail

Pharma & Healthcare Global New Generation Cancer Vaccine Market Growth 2022-2028

  • RnM4475786
  • |
  • 03 August, 2022
  • |
  • Global
  • |
  • 94 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for New Generation Cancer Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC New Generation Cancer Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States New Generation Cancer Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe New Generation Cancer Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China New Generation Cancer Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key New Generation Cancer Vaccine players cover Antigenics, Moderna, Northwest Biotherapeutics, Avax Technologies and Merck and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global New Generation Cancer Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global New Generation Cancer Vaccine market, with both quantitative and qualitative data, to help readers understand how the New Generation Cancer Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the New Generation Cancer Vaccine market and forecasts the market size by Type (Non Genetic Vaccines and Genetic Vaccines,), by Application (Cancer Research Centers, Cancer Hospital, Clinics and Others), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Non Genetic Vaccines
Genetic Vaccines

Segmentation by application
Cancer Research Centers
Cancer Hospital
Clinics
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Antigenics
Moderna
Northwest Biotherapeutics
Avax Technologies
Merck
GlaxoSmithKline

Chapter Introduction
Chapter 1: Scope of New Generation Cancer Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global New Generation Cancer Vaccine market size (sales and revenue) and CAGR, New Generation Cancer Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: New Generation Cancer Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global New Generation Cancer Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global New Generation Cancer Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Antigenics, Moderna, Northwest Biotherapeutics, Avax Technologies, Merck and GlaxoSmithKline, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global New Generation Cancer Vaccine Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for New Generation Cancer Vaccine by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for New Generation Cancer Vaccine by Country/Region, 2017, 2022 & 2028
  • 2.2 New Generation Cancer Vaccine Segment by Type
    • 2.2.1 Non Genetic Vaccines
    • 2.2.2 Genetic Vaccines
  • 2.3 New Generation Cancer Vaccine Sales by Type
    • 2.3.1 Global New Generation Cancer Vaccine Sales Market Share by Type (2017-2022)
    • 2.3.2 Global New Generation Cancer Vaccine Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global New Generation Cancer Vaccine Sale Price by Type (2017-2022)
  • 2.4 New Generation Cancer Vaccine Segment by Application
    • 2.4.1 Cancer Research Centers
    • 2.4.2 Cancer Hospital
    • 2.4.3 Clinics
    • 2.4.4 Others
  • 2.5 New Generation Cancer Vaccine Sales by Application
    • 2.5.1 Global New Generation Cancer Vaccine Sale Market Share by Application (2017-2022)
    • 2.5.2 Global New Generation Cancer Vaccine Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global New Generation Cancer Vaccine Sale Price by Application (2017-2022)

3 Global New Generation Cancer Vaccine by Company

  • 3.1 Global New Generation Cancer Vaccine Breakdown Data by Company
    • 3.1.1 Global New Generation Cancer Vaccine Annual Sales by Company (2020-2022)
    • 3.1.2 Global New Generation Cancer Vaccine Sales Market Share by Company (2020-2022)
  • 3.2 Global New Generation Cancer Vaccine Annual Revenue by Company (2020-2022)
    • 3.2.1 Global New Generation Cancer Vaccine Revenue by Company (2020-2022)
    • 3.2.2 Global New Generation Cancer Vaccine Revenue Market Share by Company (2020-2022)
  • 3.3 Global New Generation Cancer Vaccine Sale Price by Company
  • 3.4 Key Manufacturers New Generation Cancer Vaccine Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers New Generation Cancer Vaccine Product Location Distribution
    • 3.4.2 Players New Generation Cancer Vaccine Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for New Generation Cancer Vaccine by Geographic Region

  • 4.1 World Historic New Generation Cancer Vaccine Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global New Generation Cancer Vaccine Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global New Generation Cancer Vaccine Annual Revenue by Geographic Region
  • 4.2 World Historic New Generation Cancer Vaccine Market Size by Country/Region (2017-2022)
    • 4.2.1 Global New Generation Cancer Vaccine Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global New Generation Cancer Vaccine Annual Revenue by Country/Region
  • 4.3 Americas New Generation Cancer Vaccine Sales Growth
  • 4.4 APAC New Generation Cancer Vaccine Sales Growth
  • 4.5 Europe New Generation Cancer Vaccine Sales Growth
  • 4.6 Middle East & Africa New Generation Cancer Vaccine Sales Growth

5 Americas

  • 5.1 Americas New Generation Cancer Vaccine Sales by Country
    • 5.1.1 Americas New Generation Cancer Vaccine Sales by Country (2017-2022)
    • 5.1.2 Americas New Generation Cancer Vaccine Revenue by Country (2017-2022)
  • 5.2 Americas New Generation Cancer Vaccine Sales by Type
  • 5.3 Americas New Generation Cancer Vaccine Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC New Generation Cancer Vaccine Sales by Region
    • 6.1.1 APAC New Generation Cancer Vaccine Sales by Region (2017-2022)
    • 6.1.2 APAC New Generation Cancer Vaccine Revenue by Region (2017-2022)
  • 6.2 APAC New Generation Cancer Vaccine Sales by Type
  • 6.3 APAC New Generation Cancer Vaccine Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe New Generation Cancer Vaccine by Country
    • 7.1.1 Europe New Generation Cancer Vaccine Sales by Country (2017-2022)
    • 7.1.2 Europe New Generation Cancer Vaccine Revenue by Country (2017-2022)
  • 7.2 Europe New Generation Cancer Vaccine Sales by Type
  • 7.3 Europe New Generation Cancer Vaccine Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa New Generation Cancer Vaccine by Country
    • 8.1.1 Middle East & Africa New Generation Cancer Vaccine Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa New Generation Cancer Vaccine Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa New Generation Cancer Vaccine Sales by Type
  • 8.3 Middle East & Africa New Generation Cancer Vaccine Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of New Generation Cancer Vaccine
  • 10.3 Manufacturing Process Analysis of New Generation Cancer Vaccine
  • 10.4 Industry Chain Structure of New Generation Cancer Vaccine

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 New Generation Cancer Vaccine Distributors
  • 11.3 New Generation Cancer Vaccine Customer

12 World Forecast Review for New Generation Cancer Vaccine by Geographic Region

  • 12.1 Global New Generation Cancer Vaccine Market Size Forecast by Region
    • 12.1.1 Global New Generation Cancer Vaccine Forecast by Region (2023-2028)
    • 12.1.2 Global New Generation Cancer Vaccine Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global New Generation Cancer Vaccine Forecast by Type
  • 12.7 Global New Generation Cancer Vaccine Forecast by Application

13 Key Players Analysis

  • 13.1 Antigenics
    • 13.1.1 Antigenics Company Information
    • 13.1.2 Antigenics New Generation Cancer Vaccine Product Offered
    • 13.1.3 Antigenics New Generation Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Antigenics Main Business Overview
    • 13.1.5 Antigenics Latest Developments
  • 13.2 Moderna
    • 13.2.1 Moderna Company Information
    • 13.2.2 Moderna New Generation Cancer Vaccine Product Offered
    • 13.2.3 Moderna New Generation Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Moderna Main Business Overview
    • 13.2.5 Moderna Latest Developments
  • 13.3 Northwest Biotherapeutics
    • 13.3.1 Northwest Biotherapeutics Company Information
    • 13.3.2 Northwest Biotherapeutics New Generation Cancer Vaccine Product Offered
    • 13.3.3 Northwest Biotherapeutics New Generation Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Northwest Biotherapeutics Main Business Overview
    • 13.3.5 Northwest Biotherapeutics Latest Developments
  • 13.4 Avax Technologies
    • 13.4.1 Avax Technologies Company Information
    • 13.4.2 Avax Technologies New Generation Cancer Vaccine Product Offered
    • 13.4.3 Avax Technologies New Generation Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Avax Technologies Main Business Overview
    • 13.4.5 Avax Technologies Latest Developments
  • 13.5 Merck
    • 13.5.1 Merck Company Information
    • 13.5.2 Merck New Generation Cancer Vaccine Product Offered
    • 13.5.3 Merck New Generation Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Merck Main Business Overview
    • 13.5.5 Merck Latest Developments
  • 13.6 GlaxoSmithKline
    • 13.6.1 GlaxoSmithKline Company Information
    • 13.6.2 GlaxoSmithKline New Generation Cancer Vaccine Product Offered
    • 13.6.3 GlaxoSmithKline New Generation Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 GlaxoSmithKline Main Business Overview
    • 13.6.5 GlaxoSmithKline Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on New Generation Cancer Vaccine. Industry analysis & Market Report on New Generation Cancer Vaccine is a syndicated market report, published as Global New Generation Cancer Vaccine Market Growth 2022-2028. It is complete Research Study and Industry Analysis of New Generation Cancer Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,034.14
6,068.28
3,597.78
7,195.56
494,136.60
988,273.20
290,457.60
580,915.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report